Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 10 |
NetGPI | no | yes: 0, no: 10 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005634 | nucleus | 5 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: A4HK57
Term | Name | Level | Count |
---|---|---|---|
GO:0006355 | regulation of DNA-templated transcription | 6 | 11 |
GO:0006357 | regulation of transcription by RNA polymerase II | 7 | 11 |
GO:0009889 | regulation of biosynthetic process | 4 | 11 |
GO:0010468 | regulation of gene expression | 5 | 11 |
GO:0010556 | regulation of macromolecule biosynthetic process | 5 | 11 |
GO:0019219 | regulation of nucleobase-containing compound metabolic process | 5 | 11 |
GO:0019222 | regulation of metabolic process | 3 | 11 |
GO:0031323 | regulation of cellular metabolic process | 4 | 11 |
GO:0031326 | regulation of cellular biosynthetic process | 5 | 11 |
GO:0050789 | regulation of biological process | 2 | 11 |
GO:0050794 | regulation of cellular process | 3 | 11 |
GO:0051171 | regulation of nitrogen compound metabolic process | 4 | 11 |
GO:0051252 | regulation of RNA metabolic process | 5 | 11 |
GO:0060255 | regulation of macromolecule metabolic process | 4 | 11 |
GO:0065007 | biological regulation | 1 | 11 |
GO:0080090 | regulation of primary metabolic process | 4 | 11 |
GO:1903506 | regulation of nucleic acid-templated transcription | 7 | 11 |
GO:2001141 | regulation of RNA biosynthetic process | 6 | 11 |
GO:0010564 | regulation of cell cycle process | 5 | 1 |
GO:0032465 | regulation of cytokinesis | 5 | 1 |
GO:0051302 | regulation of cell division | 4 | 1 |
GO:0051726 | regulation of cell cycle | 4 | 1 |
GO:1902412 | regulation of mitotic cytokinesis | 6 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity | 5 | 11 |
GO:0019207 | kinase regulator activity | 3 | 11 |
GO:0019887 | protein kinase regulator activity | 4 | 11 |
GO:0030234 | enzyme regulator activity | 2 | 11 |
GO:0098772 | molecular function regulator activity | 1 | 11 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 174 | 176 | PF00675 | 0.460 |
CLV_NRD_NRD_1 | 265 | 267 | PF00675 | 0.436 |
CLV_NRD_NRD_1 | 45 | 47 | PF00675 | 0.379 |
CLV_NRD_NRD_1 | 71 | 73 | PF00675 | 0.343 |
CLV_PCSK_FUR_1 | 261 | 265 | PF00082 | 0.435 |
CLV_PCSK_KEX2_1 | 174 | 176 | PF00082 | 0.460 |
CLV_PCSK_KEX2_1 | 263 | 265 | PF00082 | 0.456 |
CLV_PCSK_PC1ET2_1 | 263 | 265 | PF00082 | 0.449 |
CLV_PCSK_PC7_1 | 261 | 267 | PF00082 | 0.541 |
CLV_PCSK_SKI1_1 | 122 | 126 | PF00082 | 0.375 |
CLV_PCSK_SKI1_1 | 174 | 178 | PF00082 | 0.331 |
DOC_CKS1_1 | 181 | 186 | PF01111 | 0.333 |
DOC_CYCLIN_yClb3_PxF_3 | 21 | 29 | PF00134 | 0.534 |
DOC_MAPK_gen_1 | 46 | 56 | PF00069 | 0.384 |
DOC_MAPK_gen_1 | 72 | 79 | PF00069 | 0.297 |
DOC_MAPK_MEF2A_6 | 122 | 131 | PF00069 | 0.364 |
DOC_PP4_FxxP_1 | 18 | 21 | PF00568 | 0.609 |
DOC_PP4_FxxP_1 | 181 | 184 | PF00568 | 0.310 |
DOC_PP4_FxxP_1 | 249 | 252 | PF00568 | 0.483 |
DOC_USP7_MATH_1 | 213 | 217 | PF00917 | 0.534 |
DOC_WW_Pin1_4 | 109 | 114 | PF00397 | 0.340 |
DOC_WW_Pin1_4 | 180 | 185 | PF00397 | 0.329 |
DOC_WW_Pin1_4 | 285 | 290 | PF00397 | 0.530 |
DOC_WW_Pin1_4 | 4 | 9 | PF00397 | 0.525 |
LIG_14-3-3_CanoR_1 | 150 | 156 | PF00244 | 0.472 |
LIG_14-3-3_CanoR_1 | 32 | 40 | PF00244 | 0.466 |
LIG_14-3-3_CanoR_1 | 49 | 56 | PF00244 | 0.424 |
LIG_Actin_WH2_2 | 135 | 152 | PF00022 | 0.430 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.621 |
LIG_BRCT_BRCA1_1 | 14 | 18 | PF00533 | 0.645 |
LIG_BRCT_BRCA1_1 | 27 | 31 | PF00533 | 0.271 |
LIG_BRCT_BRCA1_1 | 276 | 280 | PF00533 | 0.668 |
LIG_BRCT_BRCA1_1 | 283 | 287 | PF00533 | 0.652 |
LIG_FHA_1 | 156 | 162 | PF00498 | 0.444 |
LIG_FHA_1 | 194 | 200 | PF00498 | 0.442 |
LIG_FHA_1 | 233 | 239 | PF00498 | 0.439 |
LIG_FHA_1 | 49 | 55 | PF00498 | 0.395 |
LIG_FHA_1 | 79 | 85 | PF00498 | 0.426 |
LIG_FHA_2 | 152 | 158 | PF00498 | 0.481 |
LIG_LIR_Apic_2 | 15 | 21 | PF02991 | 0.605 |
LIG_LIR_Apic_2 | 180 | 184 | PF02991 | 0.310 |
LIG_LIR_Apic_2 | 7 | 13 | PF02991 | 0.601 |
LIG_LIR_Gen_1 | 134 | 145 | PF02991 | 0.479 |
LIG_LIR_Gen_1 | 197 | 205 | PF02991 | 0.450 |
LIG_LIR_Gen_1 | 240 | 249 | PF02991 | 0.472 |
LIG_LIR_Gen_1 | 64 | 71 | PF02991 | 0.222 |
LIG_LIR_Nem_3 | 134 | 140 | PF02991 | 0.480 |
LIG_LIR_Nem_3 | 197 | 203 | PF02991 | 0.443 |
LIG_LIR_Nem_3 | 240 | 245 | PF02991 | 0.459 |
LIG_LIR_Nem_3 | 27 | 33 | PF02991 | 0.465 |
LIG_LIR_Nem_3 | 284 | 290 | PF02991 | 0.655 |
LIG_LIR_Nem_3 | 64 | 68 | PF02991 | 0.222 |
LIG_MLH1_MIPbox_1 | 27 | 31 | PF16413 | 0.271 |
LIG_OCRL_FandH_1 | 241 | 253 | PF00620 | 0.480 |
LIG_Pex14_2 | 139 | 143 | PF04695 | 0.486 |
LIG_Pex14_2 | 177 | 181 | PF04695 | 0.309 |
LIG_Pex14_2 | 214 | 218 | PF04695 | 0.484 |
LIG_SH2_CRK | 10 | 14 | PF00017 | 0.631 |
LIG_SH2_CRK | 200 | 204 | PF00017 | 0.434 |
LIG_SH2_NCK_1 | 10 | 14 | PF00017 | 0.631 |
LIG_SH2_SRC | 22 | 25 | PF00017 | 0.547 |
LIG_SH2_STAT3 | 163 | 166 | PF00017 | 0.282 |
LIG_SH2_STAT5 | 22 | 25 | PF00017 | 0.556 |
LIG_SH2_STAT5 | 244 | 247 | PF00017 | 0.489 |
LIG_SH2_STAT5 | 30 | 33 | PF00017 | 0.380 |
LIG_SH2_STAT5 | 43 | 46 | PF00017 | 0.238 |
LIG_SH3_3 | 18 | 24 | PF00018 | 0.566 |
LIG_SH3_3 | 2 | 8 | PF00018 | 0.591 |
LIG_SUMO_SIM_anti_2 | 126 | 131 | PF11976 | 0.471 |
LIG_SUMO_SIM_par_1 | 123 | 128 | PF11976 | 0.464 |
LIG_TRAF2_1 | 165 | 168 | PF00917 | 0.476 |
LIG_TYR_ITIM | 198 | 203 | PF00017 | 0.444 |
LIG_WRC_WIRS_1 | 178 | 183 | PF05994 | 0.310 |
LIG_WRC_WIRS_1 | 23 | 28 | PF05994 | 0.547 |
MOD_CDK_SPxxK_3 | 285 | 292 | PF00069 | 0.661 |
MOD_CK1_1 | 12 | 18 | PF00069 | 0.543 |
MOD_CK1_1 | 151 | 157 | PF00069 | 0.475 |
MOD_CK1_1 | 180 | 186 | PF00069 | 0.331 |
MOD_CK1_1 | 216 | 222 | PF00069 | 0.526 |
MOD_CK1_1 | 25 | 31 | PF00069 | 0.356 |
MOD_CK1_1 | 278 | 284 | PF00069 | 0.555 |
MOD_CK2_1 | 151 | 157 | PF00069 | 0.475 |
MOD_CK2_1 | 218 | 224 | PF00069 | 0.504 |
MOD_GlcNHglycan | 218 | 221 | PF01048 | 0.543 |
MOD_GlcNHglycan | 281 | 284 | PF01048 | 0.567 |
MOD_GlcNHglycan | 35 | 38 | PF01048 | 0.489 |
MOD_GSK3_1 | 151 | 158 | PF00069 | 0.274 |
MOD_GSK3_1 | 214 | 221 | PF00069 | 0.487 |
MOD_GSK3_1 | 274 | 281 | PF00069 | 0.568 |
MOD_GSK3_1 | 4 | 11 | PF00069 | 0.560 |
MOD_GSK3_1 | 50 | 57 | PF00069 | 0.316 |
MOD_N-GLC_1 | 109 | 114 | PF02516 | 0.404 |
MOD_NEK2_1 | 131 | 136 | PF00069 | 0.359 |
MOD_NEK2_1 | 145 | 150 | PF00069 | 0.372 |
MOD_NEK2_1 | 155 | 160 | PF00069 | 0.521 |
MOD_NEK2_1 | 177 | 182 | PF00069 | 0.309 |
MOD_NEK2_1 | 194 | 199 | PF00069 | 0.309 |
MOD_NEK2_1 | 201 | 206 | PF00069 | 0.460 |
MOD_NEK2_1 | 214 | 219 | PF00069 | 0.237 |
MOD_NEK2_1 | 31 | 36 | PF00069 | 0.482 |
MOD_NEK2_1 | 50 | 55 | PF00069 | 0.197 |
MOD_NEK2_1 | 79 | 84 | PF00069 | 0.304 |
MOD_PIKK_1 | 264 | 270 | PF00454 | 0.600 |
MOD_PIKK_1 | 31 | 37 | PF00454 | 0.464 |
MOD_PKA_1 | 264 | 270 | PF00069 | 0.569 |
MOD_PKA_2 | 264 | 270 | PF00069 | 0.461 |
MOD_PKA_2 | 31 | 37 | PF00069 | 0.464 |
MOD_PKA_2 | 48 | 54 | PF00069 | 0.424 |
MOD_Plk_4 | 194 | 200 | PF00069 | 0.411 |
MOD_Plk_4 | 275 | 281 | PF00069 | 0.629 |
MOD_Plk_4 | 50 | 56 | PF00069 | 0.324 |
MOD_ProDKin_1 | 109 | 115 | PF00069 | 0.340 |
MOD_ProDKin_1 | 180 | 186 | PF00069 | 0.331 |
MOD_ProDKin_1 | 285 | 291 | PF00069 | 0.527 |
MOD_ProDKin_1 | 4 | 10 | PF00069 | 0.527 |
MOD_SUMO_for_1 | 88 | 91 | PF00179 | 0.424 |
TRG_ENDOCYTIC_2 | 200 | 203 | PF00928 | 0.448 |
TRG_ENDOCYTIC_2 | 30 | 33 | PF00928 | 0.402 |
TRG_ER_diArg_1 | 173 | 175 | PF00400 | 0.459 |
TRG_ER_diArg_1 | 264 | 266 | PF00400 | 0.429 |
TRG_NES_CRM1_1 | 133 | 147 | PF08389 | 0.425 |
TRG_NES_CRM1_1 | 230 | 240 | PF08389 | 0.473 |
TRG_NLS_Bipartite_1 | 247 | 267 | PF00514 | 0.403 |
TRG_NLS_MonoCore_2 | 262 | 267 | PF00514 | 0.547 |
TRG_NLS_MonoExtN_4 | 261 | 267 | PF00514 | 0.445 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1PFK2 | Leptomonas seymouri | 78% | 100% |
A0A1X0NWC7 | Trypanosomatidae | 34% | 100% |
A0A2D1QVA3 | Leishmania donovani | 93% | 100% |
A0A422N086 | Trypanosoma rangeli | 34% | 100% |
A4I7P3 | Leishmania infantum | 92% | 100% |
D0A9U6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 33% | 100% |
E9B2K0 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |
Q4Q5K6 | Leishmania major | 90% | 100% |
V5BFB1 | Trypanosoma cruzi | 35% | 100% |